PKN1/2-IN-1（Cat No.:I043973）is a potent, selective inhibitor targeting Protein Kinase N 1 and 2 (PKN1 and PKN2), which are serine/threonine kinases involved in regulating cellular processes such as cell motility, survival, and the actin cytoskeleton. These kinases are implicated in various cancer-related pathways and play roles in cellular responses to stress and inflammation. By inhibiting PKN1 and PKN2, PKN1/2-IN-1 disrupts tumor cell proliferation, migration, and metastasis. It has shown promising preclinical results in cancer research, offering potential as a therapeutic agent for various solid tumors and inflammatory conditions.